In this webinar, Ovacome are joined by Professor Gordon Jayson BM, BA, Bch, FRCP, PhD, professor of oncology at The Christie in Manchester.
Professor Jayson talks about the latest in treating ovarian cancer with anti-angiogenic agents, such as bevacizumab (also known under the brand name Avastin).
For ovarian cancer information and support, call 0800 008 7054 or visit www.ovacome.org.uk/
9 июл 2024